tradingkey.logo

Surgery Partners Inc

SGRY
查看詳細走勢圖
16.120USD
+0.410+2.61%
收盤 01/09, 16:00美東報價延遲15分鐘
2.08B總市值
虧損本益比TTM

Surgery Partners Inc

16.120
+0.410+2.61%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+2.61%

5天

+5.64%

1月

-2.48%

6月

-27.63%

今年開始到現在

+4.34%

1年

-21.94%

查看詳細走勢圖

TradingKey Surgery Partners Inc股票評分

單位: USD 更新時間: 2026-01-09

操作建議

Surgery Partners Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療服務供應商行業排名20/77位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為26.00。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Surgery Partners Inc評分

相關信息

行業排名
20 / 77
全市場排名
114 / 4562
所屬行業
醫療服務供應商

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Surgery Partners Inc亮點

亮點風險
Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
業績高增長
公司營業收入穩步增長,連續3年增長22.64%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入3.11B美元
估值高估
公司最新PE估值-11.89,處於3年歷史高位
機構減倉
最新機構持股153.39M股,環比減少10.22%
CI 精選加拿大股票基金持倉
明星投資者CI 精選加拿大股票基金持倉,最新持倉268.00股

分析師目標

基於 12 分析師
買入
評級
26.000
目標均價
+69.49%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Surgery Partners Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Surgery Partners Inc簡介

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility Services segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of 162 surgical facilities comprised of 143 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 250 locations in 30 states, including short-stay surgical hospitals.
公司代碼SGRY
公司Surgery Partners Inc
CEOEvans (J. Eric)
網址https://surgerypartners.com/

常見問題

Surgery Partners Inc(SGRY)的當前股價是多少?

Surgery Partners Inc(SGRY)的當前股價是 16.120。

Surgery Partners Inc 的股票代碼是什麼?

Surgery Partners Inc的股票代碼是SGRY。

Surgery Partners Inc股票的52週最高點是多少?

Surgery Partners Inc股票的52週最高點是26.160。

Surgery Partners Inc股票的52週最低點是多少?

Surgery Partners Inc股票的52週最低點是14.940。

Surgery Partners Inc的市值是多少?

Surgery Partners Inc的市值是2.08B。

Surgery Partners Inc的淨利潤是多少?

Surgery Partners Inc的淨利潤為-168.10M。

現在Surgery Partners Inc(SGRY)的股票是買入、持有還是賣出?

根據分析師評級,Surgery Partners Inc(SGRY)的總體評級為買入,目標價格為26.000。

Surgery Partners Inc(SGRY)股票的每股收益(EPS TTM)是多少

Surgery Partners Inc(SGRY)股票的每股收益(EPS TTM)是-1.356。
KeyAI